• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用广义线性混合效应模型衡量医学或行为治疗的个体获益。

Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed-effects models.

作者信息

Diaz Francisco J

机构信息

Department of Biostatistics, The University of Kansas Medical Center, Mail Stop 1026, 3901 Rainbow Blvd., Kansas City, 66160, KS, U.S.A.

出版信息

Stat Med. 2016 Oct 15;35(23):4077-92. doi: 10.1002/sim.7005. Epub 2016 Jun 20.

DOI:10.1002/sim.7005
PMID:27323698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5012921/
Abstract

We propose statistical definitions of the individual benefit of a medical or behavioral treatment and of the severity of a chronic illness. These definitions are used to develop a graphical method that can be used by statisticians and clinicians in the data analysis of clinical trials from the perspective of personalized medicine. The method focuses on assessing and comparing individual effects of treatments rather than average effects and can be used with continuous and discrete responses, including dichotomous and count responses. The method is based on new developments in generalized linear mixed-effects models, which are introduced in this article. To illustrate, analyses of data from the Sequenced Treatment Alternatives to Relieve Depression clinical trial of sequences of treatments for depression and data from a clinical trial of respiratory treatments are presented. The estimation of individual benefits is also explained. Copyright © 2016 John Wiley & Sons, Ltd.

摘要

我们提出了医学或行为治疗个体获益以及慢性病严重程度的统计学定义。这些定义用于开发一种图形方法,统计学家和临床医生可在个性化医疗视角下的临床试验数据分析中使用该方法。该方法侧重于评估和比较治疗的个体效果而非平均效果,可用于连续和离散反应,包括二分反应和计数反应。该方法基于广义线性混合效应模型的新进展,本文对此进行了介绍。为作说明,给出了抑郁症治疗序列的缓解抑郁症的序贯治疗替代方案临床试验数据以及呼吸治疗临床试验数据的分析。还解释了个体获益的估计方法。版权所有© 2016约翰威立父子有限公司。

相似文献

1
Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed-effects models.使用广义线性混合效应模型衡量医学或行为治疗的个体获益。
Stat Med. 2016 Oct 15;35(23):4077-92. doi: 10.1002/sim.7005. Epub 2016 Jun 20.
2
A graphical approach to assess the goodness-of-fit of random-effects linear models when the goal is to measure individual benefits of medical treatments in severely ill patients.一种图形化方法,用于评估随机效应线性模型的拟合优度,目标是测量重病患者中医疗效果的个体获益。
BMC Med Res Methodol. 2020 Jul 20;20(1):193. doi: 10.1186/s12874-020-01054-3.
3
Estimating individual benefits of medical or behavioral treatments in severely ill patients.估算重病患者接受医疗或行为治疗的个体获益。
Stat Methods Med Res. 2019 Mar;28(3):911-927. doi: 10.1177/0962280217739033. Epub 2017 Nov 8.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Graphical approaches using a Bonferroni mixture of weighted Simes tests.使用加权Simes检验的Bonferroni混合法的图形方法。
Stat Med. 2016 Sep 30;35(22):4041-55. doi: 10.1002/sim.6985. Epub 2016 May 25.
6
Use of generalized linear mixed models for network meta-analysis.广义线性混合模型在网状Meta分析中的应用。
Med Decis Making. 2014 Oct;34(7):911-8. doi: 10.1177/0272989X14545789.
7
Estimation of group means in generalized linear mixed models.广义线性混合模型中组均值的估计。
Pharm Stat. 2020 Sep;19(5):646-661. doi: 10.1002/pst.2022. Epub 2020 Apr 6.
8
SIMEX variance component tests in generalized linear mixed measurement error models.广义线性混合测量误差模型中的SIMEX方差分量检验
Biometrics. 1999 Jun;55(2):613-9. doi: 10.1111/j.0006-341x.1999.00613.x.
9
Semiparametric estimation in generalized linear mixed models with auxiliary covariates: a pairwise likelihood approach.具有辅助协变量的广义线性混合模型中的半参数估计:一种成对似然方法。
Biometrics. 2014 Dec;70(4):910-9. doi: 10.1111/biom.12208. Epub 2014 Sep 23.
10
Semiparametric hazard function estimation in meta-analysis for time to event data.荟萃分析中时变数据半参数风险函数估计。
Res Synth Methods. 2012 Sep;3(3):240-9. doi: 10.1002/jrsm.1047. Epub 2012 Jul 19.

引用本文的文献

1
Active Ingredients of Voice Therapy for Muscle Tension Voice Disorders: A Retrospective Data Audit.肌肉紧张性嗓音障碍嗓音治疗的活性成分:一项回顾性数据审计
J Clin Med. 2021 Sep 14;10(18):4135. doi: 10.3390/jcm10184135.
2
Using population crossover trials to improve the decision process regarding treatment individualization in N-of-1 trials.利用群体交叉试验改进 N-of-1 试验中关于个体化治疗决策的过程。
Stat Med. 2021 Sep 10;40(20):4345-4361. doi: 10.1002/sim.9030. Epub 2021 Jul 2.
3
Improvement in the long-term care burden after surgical treatment of patients with idiopathic normal pressure hydrocephalus: a supplementary study.

本文引用的文献

1
Mastering variation: variance components and personalised medicine.掌握变异:方差分量与个性化医疗
Stat Med. 2016 Mar 30;35(7):966-77. doi: 10.1002/sim.6739. Epub 2015 Sep 28.
2
Effect model law: an approach for the implementation of personalized medicine.效应模型定律:实施个性化医疗的一种方法。
J Pers Med. 2013 Aug 15;3(3):177-90. doi: 10.3390/jpm3030177.
3
Can valproic acid be an inducer of clozapine metabolism?丙戊酸会是氯氮平代谢的诱导剂吗?
特发性正常压力脑积水患者手术后长期护理负担的改善:一项补充研究。
Sci Rep. 2021 Jun 3;11(1):11732. doi: 10.1038/s41598-021-90911-2.
4
A graphical approach to assess the goodness-of-fit of random-effects linear models when the goal is to measure individual benefits of medical treatments in severely ill patients.一种图形化方法,用于评估随机效应线性模型的拟合优度,目标是测量重病患者中医疗效果的个体获益。
BMC Med Res Methodol. 2020 Jul 20;20(1):193. doi: 10.1186/s12874-020-01054-3.
5
Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users.使用纵向二分类结局衡量精神科治疗的个体获益:非大麻和大麻使用者抗精神病药物获益的应用。
J Biopharm Stat. 2020 Sep 2;30(5):916-940. doi: 10.1080/10543406.2020.1765371. Epub 2020 Jun 8.
6
Construction of the Design Matrix for Generalized Linear Mixed-Effects Models in the Context of Clinical Trials of Treatment Sequences.治疗序列临床试验背景下广义线性混合效应模型设计矩阵的构建
Rev Colomb Estad. 2018 Jul;41(2):191-233. doi: 10.15446/rce.v41n2.63332.
7
Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder.个体化治疗注意缺陷多动障碍儿童的哌醋甲酯剂量。
BMC Med Res Methodol. 2020 Mar 11;20(1):56. doi: 10.1186/s12874-020-00934-y.
8
Optimization of Diagnosis and Treatment of Chronic Diseases Based on Association Analysis Under the Background of Regional Integration.基于区域一体化背景下的关联分析优化慢性病的诊断和治疗。
J Med Syst. 2019 Jan 19;43(3):46. doi: 10.1007/s10916-019-1169-9.
9
The Supporting Patient Activation in Transition to Home (sPATH) intervention: a study protocol of a randomised controlled trial using motivational interviewing to decrease re-hospitalisation for patients with COPD or heart failure.支持患者过渡到家庭的激活(sPATH)干预:一项随机对照试验的研究方案,该试验采用动机性访谈来降低慢性阻塞性肺疾病(COPD)或心力衰竭患者的再次住院率。
BMJ Open. 2017 Jul 10;7(7):e014178. doi: 10.1136/bmjopen-2016-014178.
Pharmacopsychiatry. 2014 May;47(3):89-96. doi: 10.1055/s-0034-1371866. Epub 2014 Apr 24.
4
Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs.随机效应线性模型和两种特殊交叉设计平均生物等效性研究的样本量表:四周期、两序列、两制剂和六周期、三序列、三制剂设计。
Clin Pharmacokinet. 2013 Dec;52(12):1033-43. doi: 10.1007/s40262-013-0103-4.
5
The mathematics of drug dose individualization should be built with random-effects linear models.药物剂量个体化的数学模型应基于随机效应线性模型构建。
Ther Drug Monit. 2013 Apr;35(2):276-7. doi: 10.1097/FTD.0b013e318283e3c6.
6
Role of Statistical Random-Effects Linear Models in Personalized Medicine.统计随机效应线性模型在个性化医疗中的作用。
Curr Pharmacogenomics Person Med. 2012 Mar;10(1):22-32. doi: 10.2174/1875692111201010022.
7
Drug dosage individualization based on a random-effects linear model.基于随机效应线性模型的药物剂量个体化
J Biopharm Stat. 2012;22(3):463-84. doi: 10.1080/10543406.2010.547264.
8
Residuals and outliers in replicate design crossover studies.重复设计交叉研究中的残差与异常值
J Biopharm Stat. 2010 Jul;20(4):835-49. doi: 10.1080/10543401003618876.
9
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model.使用混合模型评估合并用药对血浆奥氮平浓度的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1453-8. doi: 10.1016/j.pnpbp.2008.04.018. Epub 2008 May 7.
10
Individualizing drug dosage by using a random intercept linear model.使用随机截距线性模型个体化药物剂量。
Stat Med. 2007 Apr 30;26(9):2052-73. doi: 10.1002/sim.2636.